{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:16:45Z","timestamp":1790745405798,"version":"4.1.0"},"reference-count":78,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-CA225088"],"award-info":[{"award-number":["U54-CA225088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA211681"],"award-info":[{"award-number":["CA211681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["W911NF2010255"],"award-info":[{"award-number":["W911NF2010255"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE1745303"],"award-info":[{"award-number":["DGE1745303"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-HL127365"],"award-info":[{"award-number":["U54-HL127365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,5,26]]},"abstract":"<jats:p>\n                    Deubiquitinating enzymes (DUBs), ~100 of which are found in human cells, are proteases that remove ubiquitin conjugates from proteins, thereby regulating protein turnover. They are involved in a wide range of cellular activities and are emerging therapeutic targets for cancer and other diseases. Drugs targeting USP1 and USP30 are in clinical development for cancer and kidney disease respectively. However, the majority of substrates and pathways regulated by DUBs remain unknown, impeding efforts to prioritize specific enzymes for research and drug development. To assemble a knowledgebase of DUB activities, co-dependent genes, and substrates, we combined targeted experiments using CRISPR libraries and inhibitors with systematic mining of functional genomic databases. Analysis of the Dependency Map, Connectivity Map, Cancer Cell Line Encyclopedia, and multiple protein-protein interaction databases yielded specific hypotheses about DUB function, a subset of which were confirmed in follow-on experiments. The data in this paper are browsable online in a newly developed\n                    <jats:ext-link ext-link-type=\"uri\" xlink:href=\"https:\/\/labsyspharm.github.io\/dubportal\/\">DUB Portal<\/jats:ext-link>\n                    and promise to improve understanding of DUBs as a family as well as the activities of incompletely characterized DUBs (e.g. USPL1 and USP32) and those already targeted with investigational cancer therapeutics (e.g. USP14, UCHL5, and USP7).\n                  <\/jats:p>","DOI":"10.7554\/elife.72879","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T04:15:17Z","timestamp":1653624917000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.72879","source":"Crossref","is-referenced-by-count":48,"title":["Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes"],"prefix":"10.7554","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8171-5109","authenticated-orcid":true,"given":"Laura M","family":"Doherty","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05av6m066","id-type":"ROR","asserted-by":"publisher"}],"name":"Harvard Medical School (HMS) Library of Integrated Network-based Cellular Signatures (LINCS) Center","place":["Cambridge, United States"]},{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute","place":["Boston, United States"]},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School","place":["Boston, United States"]},{"id":[{"id":"https:\/\/ror.org\/00tdyb139","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-4084","authenticated-orcid":true,"given":"Caitlin E","family":"Mills","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00tdyb139","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3118-3378","authenticated-orcid":true,"given":"Sarah A","family":"Boswell","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00tdyb139","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute","place":["Boston, United States"]},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-4370","authenticated-orcid":true,"given":"Charles Tapley","family":"Hoyt","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00tdyb139","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-5346","authenticated-orcid":true,"given":"Benjamin","family":"Gyori","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00tdyb139","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-1823","authenticated-orcid":true,"given":"Sara J","family":"Buhrlage","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute","place":["Boston, United States"]},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-1838","authenticated-orcid":true,"given":"Peter K","family":"Sorger","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00tdyb139","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School","place":["Boston, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/anie.201608672","article-title":"Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5","volume":"56","author":"Altmann","year":"2017","journal-title":"Angewandte Chemie (International Ed. in English)"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061579","article-title":"Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics","volume":"12","author":"Antao","year":"2020","journal-title":"Cancers"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00063","article-title":"Ubiquitin pathways in neurodegenerative disease","volume":"7","author":"Atkin","year":"2014","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"bib4","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2211-5","article-title":"FamPlex: a resource for entity recognition and relationship resolution of human protein families and complexes in biomedical text mining","volume":"19","author":"Bachman","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13331","article-title":"A novel p53 regulator, C16ORF72\/TAPR1, buffers against telomerase inhibition","volume":"20","author":"Benslimane","year":"2021","journal-title":"Aging Cell"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2020.09.005","article-title":"Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors","volume":"28","author":"Bushman","year":"2021","journal-title":"Cell Chemical Biology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1158\/1078-0432.CCR-12-3696","article-title":"USP8 is a novel target for overcoming gefitinib resistance in lung cancer","volume":"19","author":"Byun","year":"2013","journal-title":"Clinical Cancer Research"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"D685","DOI":"10.1093\/nar\/gkq1039","article-title":"Pathway Commons, a web resource for biological pathway data","volume":"39","author":"Cerami","year":"2011","journal-title":"Nucleic Acids Research"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the \u201cundruggable\u201d cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nature Reviews. Cancer"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2217\/fon.11.39","article-title":"Ubiquitin-Specific Proteases as Druggable Targets","volume":"2","author":"Davis","year":"2015","journal-title":"Drug Target Review"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbrc.2010.08.082","article-title":"Regulation of the Polycomb protein RING1B ubiquitination by USP7","volume":"400","author":"de Bie","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/nar\/gky1219","article-title":"The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin","volume":"47","author":"de Vivo","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1042\/BST20190527","article-title":"Ubiquitin-specific protease 8 (USP8\/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions","volume":"47","author":"Dufner","year":"2019","journal-title":"Biochemical Society Transactions"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/nm.2536","article-title":"Inhibition of proteasome deubiquitinating activity as a new cancer therapy","volume":"17","author":"D\u2019Arcy","year":"2011","journal-title":"Nature Medicine"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10565-019-09491-7","article-title":"Genome-wide off-targets of drugs: risks and opportunities","volume":"35","author":"Giri","year":"2019","journal-title":"Cell Biology and Toxicology"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.3390\/cells5030034","article-title":"Multiple Roles of the Small GTPase Rab7","volume":"5","author":"Guerra","year":"2016","journal-title":"Cells"},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20177651","article-title":"From word models to executable models of signaling networks using automated assembly","volume":"13","author":"Gyori","year":"2017","journal-title":"Molecular Systems Biology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"D452","DOI":"10.1093\/nar\/gkh052","article-title":"IntAct: an open source molecular interaction database","volume":"32","author":"Hermjakob","year":"2004","journal-title":"Nucleic Acids Research"},{"key":"bib20","article-title":"DUB Portal","volume-title":"GitHub","author":"Hoyt","year":"2022","unstructured":"Hoyt CT. 2022. DUB Portal. GitHub. https:\/\/github.com\/labsyspharm\/dubportal."},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1242\/jcs.141788","article-title":"A role for the Cajal-body-associated SUMO isopeptidase USPL1 in snRNA transcription mediated by RNA polymerase II","volume":"127","author":"Hutten","year":"2014","journal-title":"Journal of Cell Science"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.2147\/OTT.S182721","article-title":"Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma","volume":"11","author":"Kakadia","year":"2018","journal-title":"OncoTargets and Therapy"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nature24006","article-title":"USP7 small-molecule inhibitors interfere with ubiquitin binding","volume":"550","author":"Kategaya","year":"2017","journal-title":"Nature"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev.cellbio.22.010605.093503","article-title":"Modification of proteins by ubiquitin and ubiquitin-like proteins","volume":"22","author":"Kerscher","year":"2006","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1016\/j.jmb.2017.05.028","article-title":"Regulation of USP7: A High Incidence of E3 Complexes","volume":"429","author":"Kim","year":"2017","journal-title":"Journal of Molecular Biology"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/j.bmcl.2018.05.013","article-title":"Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy","volume":"28","author":"Kluge","year":"2018","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annual Review of Biochemistry"},{"key":"bib29","article-title":"A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients With Advanced Solid Tumors","author":"KSQ Therapeutics, Inc","year":"2022","unstructured":"KSQ Therapeutics, Inc. 2022. A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients With Advanced Solid Tumors. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05240898 [Accessed June 8, 2022]."},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science (New York, N.Y.)"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.chembiol.2017.09.003","article-title":"Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7","volume":"24","author":"Lamberto","year":"2017","journal-title":"Cell Chemical Biology"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000489750","article-title":"Inactivation of USP14 Perturbs Ubiquitin Homeostasis and Delays the Cell Cycle in Mouse Embryonic Fibroblasts and in Fruit Fly Drosophila","volume":"47","author":"Lee","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics (Oxford, England)"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yexcr.2005.01.022","article-title":"Characterization of the human GARP (Golgi associated retrograde protein) complex","volume":"306","author":"Liewen","year":"2005","journal-title":"Experimental Cell Research"},{"key":"bib35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2000733","article-title":"The Machado-Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53","volume":"14","author":"Liu","year":"2016","journal-title":"PLOS Biology"},{"key":"bib36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07185-y","article-title":"Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN","volume":"9","author":"Liu","year":"2018","journal-title":"Nature Communications"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/cdd.2017.46","article-title":"CYLD, A20 and OTULIN deubiquitinases in NF-\u03baB signaling and cell death: so similar, yet so different","volume":"24","author":"Lork","year":"2017","journal-title":"Cell Death and Differentiation"},{"key":"bib38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015891","article-title":"An atlas of altered expression of deubiquitinating enzymes in human cancer","volume":"6","author":"Luise","year":"2011","journal-title":"PLOS ONE"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cell.2011.05.006","article-title":"Analysis of the human endogenous coregulator complexome","volume":"145","author":"Malovannaya","year":"2011","journal-title":"Cell"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aad0848","article-title":"ESCRT proteins restrict constitutive NF-\u03baB signaling by trafficking cytokine receptors","volume":"9","author":"Mami\u0144ska","year":"2016","journal-title":"Science Signaling"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1073\/pnas.121616198","article-title":"Short tandem repeat profiling provides an international reference standard for human cell lines","volume":"98","author":"Masters","year":"2001","journal-title":"PNAS"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nature Genetics"},{"key":"bib43","article-title":"Mission Therapeutics authorised to initiate first clinical trial for lead DUB program, MTX652, in kidney disease","author":"Mission Therapeutics","year":"2022","unstructured":"Mission Therapeutics. 2022. Mission Therapeutics authorised to initiate first clinical trial for lead DUB program, MTX652, in kidney disease. https:\/\/missiontherapeutics.com\/category\/press-release\/ [Accessed June 8, 2022]."},{"key":"bib44","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10592-018-1072-9","article-title":"The International Mouse Phenotyping Consortium (IMPC): a functional catalogue of the mammalian genome that informs conservation","volume":"19","author":"Mu\u00f1oz-Fuentes","year":"2018","journal-title":"Conservation Genetics (Print)"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02705243","article-title":"The ubiquitin-proteasome system","volume":"31","author":"Nandi","year":"2006","journal-title":"Journal of Biosciences"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1021\/jm501061a","article-title":"Inhibiting the deubiquitinating enzymes (DUBs","volume":"58","author":"Ndubaku","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative Proteomics of the Cancer Cell Line Encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.tranon.2019.05.005","article-title":"Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma","volume":"12","author":"Ohashi","year":"2019","journal-title":"Translational Oncology"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"956","DOI":"10.15252\/embr.201438679","article-title":"UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells","volume":"15","author":"Oka","year":"2014","journal-title":"EMBO Reports"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cels.2018.04.011","article-title":"Interrogation of Mammalian Protein Complex Structure, Function, and Membership Using Genome-Scale Fitness Screens","volume":"6","author":"Pan","year":"2018","journal-title":"Cell Systems"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/B978-0-12-800147-9.00002-9","article-title":"The ubiquitin system in immune regulation","volume":"124","author":"Park","year":"2014","journal-title":"Advances in Immunology"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nature Medicine"},{"key":"bib53","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1131-1","article-title":"Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner","volume":"38","author":"Qin","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1101\/gr.128124.111","article-title":"Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture","volume":"22","author":"Rohland","year":"2012","journal-title":"Genome Research"},{"key":"bib55","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database"},{"key":"bib56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09437-x","article-title":"USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7","volume":"10","author":"Sapmaz","year":"2019","journal-title":"Nature Communications"},{"key":"bib57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62076-x","article-title":"Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism","volume":"10","author":"Schauer","year":"2020","journal-title":"Scientific Reports"},{"key":"bib58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13166","article-title":"Targeted inhibition of the COP9 signalosome for treatment of cancer","volume":"7","author":"Schlierf","year":"2016","journal-title":"Nature Communications"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/embor.2012.125","article-title":"Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions","volume":"13","author":"Schulz","year":"2012","journal-title":"EMBO Reports"},{"key":"bib60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01076-4","article-title":"Dynamics of lineage commitment revealed by single-cell transcriptomics of differentiating embryonic stem cells","volume":"8","author":"Semrau","year":"2017","journal-title":"Nature Communications"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4161\/cbt.10.8.13417","article-title":"Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets","volume":"10","author":"Shi","year":"2010","journal-title":"Cancer Biology & Therapy"},{"key":"bib62","doi-asserted-by":"publisher","DOI":"10.1101\/003236","article-title":"Characterization of Directed Differentiation by High-Throughput Single-Cell RNA-Seq","volume-title":"bioRxiv","author":"Soumillon","year":"2014"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"D535","DOI":"10.1093\/nar\/gkj109","article-title":"BioGRID: a general repository for interaction datasets","volume":"34","author":"Stark","year":"2006","journal-title":"Nucleic Acids Research"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40262-018-0679-9","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib","volume":"58","author":"Tan","year":"2019","journal-title":"Clinical Pharmacokinetics"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood-2013-05-500033","article-title":"A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance","volume":"123","author":"Tian","year":"2014","journal-title":"Blood"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer Dependency Map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/gbe\/evx020","article-title":"The evolution and functional diversification of the deubiquitinating enzyme superfamily","volume":"9","author":"Vlasschaert","year":"2017","journal-title":"Genome Biology and Evolution"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41422-018-0091-x","article-title":"Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Research"},{"key":"bib70","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0208-z","article-title":"Targeting deubiquitinase USP28 for cancer therapy","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death & Disease"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/nchembio.2486","article-title":"Inhibition of USP10 induces degradation of oncogenic FLT3","volume":"13","author":"Weisberg","year":"2017","journal-title":"Nature Chemical Biology"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1083\/jcb.147.4.743","article-title":"Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells","volume":"147","author":"White","year":"1999","journal-title":"The Journal of Cell Biology"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1242\/jcs.041046","article-title":"DUBs at a glance","volume":"122","author":"Wilkinson","year":"2009","journal-title":"Journal of Cell Science"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1021\/acschembio.7b00334","article-title":"Identification and Characterization of Dual Inhibitors of the USP25\/28 Deubiquitinating Enzyme Subfamily","volume":"12","author":"Wrigley","year":"2017","journal-title":"ACS Chemical Biology"},{"key":"bib75","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0086-y","article-title":"Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer","volume":"7","author":"Xia","year":"2018","journal-title":"Oncogenesis"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.molcel.2008.08.027","article-title":"Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex","volume":"31","author":"Yao","year":"2008","journal-title":"Molecular Cell"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/jmcb\/mjaa024","article-title":"A \u201cGoldmine\u201d for digging cancer-specific targets: the genes essential for embryo development but non-essential for adult life","volume":"12","author":"Yu","year":"2020","journal-title":"Journal of Molecular Cell Biology"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1573406413666171020115539","article-title":"USP7: Target Validation and Drug Discovery for Cancer Therapy","volume":"14","author":"Zhou","year":"2018","journal-title":"Medicinal Chemistry (Shariqah (United Arab Emirates))"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/72879\/elife-72879-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/72879\/elife-72879-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/72879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:07:27Z","timestamp":1697058447000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/72879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":78,"alternative-id":["10.7554\/eLife.72879"],"URL":"https:\/\/doi.org\/10.7554\/elife.72879","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.06.455458","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2021.08.06.455458","asserted-by":"object"}],"references":[{"id-type":"accession","id":"Protein Complexes","asserted-by":"subject"},{"id-type":"accession","id":"CCLE proteomics","asserted-by":"subject"}],"is-supplemented-by":[{"id-type":"accession","id":"syn25008209","asserted-by":"subject"},{"id-type":"accession","id":"syn25008216","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.72879.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.72879.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.72879.sa0","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e72879"}}